Development of Caspofungin Resistance following Prolonged Therapy for Invasive Candidiasis Secondary to Candida glabrata Infection
Open Access
- 1 October 2008
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 52 (10), 3783-3785
- https://doi.org/10.1128/aac.00473-08
Abstract
We report a case of Candida glabrata invasive candidiasis that developed reduced susceptibility to caspofungin during prolonged therapy. Pre- and posttreatment isolates were confirmed to be isogenic, and sequencing of hot spots known to confer echinocandin resistance revealed an F659V substitution within the FKS2 region of the glucan synthase complex.Keywords
This publication has 24 references indexed in Scilit:
- Reduced Candida glabrata Susceptibility Secondary to an FKS1 Mutation Developed during Candidemia TreatmentAntimicrobial Agents and Chemotherapy, 2008
- Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive CandidiasisClinical Infectious Diseases, 2007
- Anidulafungin versus Fluconazole for Invasive CandidiasisNew England Journal of Medicine, 2007
- Serum Differentially Alters the Antifungal Properties of Echinocandin DrugsAntimicrobial Agents and Chemotherapy, 2007
- Acquired Echinocandin Resistance in a Candida krusei Isolate Due to Modification of Glucan SynthaseAntimicrobial Agents and Chemotherapy, 2007
- In Vivo Efficacy of Anidulafungin and Caspofungin against Candida glabrata and Association with In Vitro Potency in the Presence of SeraAntimicrobial Agents and Chemotherapy, 2007
- Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trialThe Lancet, 2007
- In Vitro Pharmacodynamics of Anidulafungin and Caspofungin against Candida glabrata Isolates, Including Strains with Decreased Caspofungin SusceptibilityAntimicrobial Agents and Chemotherapy, 2006
- Candida albicans and Candida glabrata Clinical Isolates Exhibiting Reduced Echinocandin SusceptibilityAntimicrobial Agents and Chemotherapy, 2006
- Specific Substitutions in the Echinocandin Target Fks1p Account for Reduced Susceptibility of Rare Laboratory and Clinical Candida sp. IsolatesAntimicrobial Agents and Chemotherapy, 2005